Researchers dig into past data to predict kidney decline in advanced PKD patients
NCT ID NCT06193616
First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study looks back at medical records of 70 adults with advanced polycystic kidney disease (stage IV CKD) who are taking the drug octreotide LAR. The goal is to find out which early signs, like kidney size, best predict how fast kidney function will get worse over time. No new treatments are being tested; instead, researchers hope to learn more about the disease to help guide future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ASST HPG23 - Unità di Nefrologia
Bergamo, BG, 24100, Italy
Conditions
Explore the condition pages connected to this study.